Related Experiment Videos
The parietal cell as a therapeutic target.
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1986
Summary
Understanding the H+K+ATPase enzyme is key to developing new treatments for upper gastrointestinal ulcers. Specific inhibitors targeting this enzyme could potentially halt acid secretion effectively.
Area of Science:
- Gastroenterology
- Molecular Biology
- Pharmacology
Background:
- Upper gastrointestinal tract ulcers are treated by inhibiting acid secretion or improving mucosal resistance.
- Acid secretion is primarily initiated by H2-histamine receptor activation, with contributions from other receptors.
- Parietal cell activation by histamine involves adenylate cyclase and cyclic AMP, mimicking H2-receptor activation.
Purpose of the Study:
- To model parietal cell activation by integrating histamine, cholinergic, and gastrinergic systems.
- To identify potential sites for therapeutic intervention within the parietal cell activation pathway.
- To investigate the H+K+ATPase enzyme for the development of specific acid secretion inhibitors.
Main Methods:
- Construction of a parietal cell activation model.
- Analysis of metabolic, structural, and H+ pump function changes.
- Detailed biochemical studies on hog gastric mucosa H+K+ATPase.
Main Results:
- A reaction sequence for H+K+ATPase has been proposed, correlating with enzyme transport functions.
- The molecular weight of H+K+ATPase is 94,000, with partial amino acid sequencing completed.
- Second messengers like cyclic AMP and Ca2+ activate phosphokinases, suggesting multiple intervention sites.
Conclusions:
- Further precise knowledge of H+K+ATPase may enable the design of specific inhibitors.
- Targeting the terminal step of acid secretion with specific inhibitors could offer complete inhibition in therapeutic doses.
- Understanding parietal cell mechanisms provides a foundation for novel ulcer treatment strategies.